TotalMarketCap

Market cap

$109.748 M

$2.52 -10.95%

Close of 6 Nov 2026

As of 6 Nov 2026, Pulmonx (LUNG) has a market capitalization of $109.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$90.5M

#2516 by revenue

Earnings

-$54.0M

Loss-making

Shares outstanding

43,550,665

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #72Apyx MedicalAPYX$126.8M
  2. #73PolyPidPYPD$114.8M
  3. #74PulmonxLUNG$109.7M
  4. #75NyxoahNYXH$81.3M
  5. #76Lucid DiagnosticsLUCD$79.6M

What if Pulmonx were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for Pulmonx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.